Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

13

Number of overlapping holdings

9.6%

% of XBI's 136 holdings also in LFSC

41.9%

% of LFSC's 31 holdings also in XBI

Overlap by Weight
Sector Drift (XBI minus LFSC)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in XBI
Weight
in LFSC
Overlap
SAREPTA THERAPEUTICS INC 2.7% 4.1% 2.7%
UNITED THERAPEUTICS CORP 2.9% 2.6% 2.6%
INSMED INC 2.6% 6.0% 2.6%
BLUEPRINT MEDICINES CORP. 1.7% 5.7% 1.7%
MADRIGAL PHARMACEUTICALS, INC. 2.2% 1.4% 1.4%

Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to LFSC
NATERA INC 3.5%
GILEAD SCIENCES INC 3.0%
INCYTE CORP 2.9%
ADVENTRX PHARMACEUTICALS INC 2.8%
NEUROCRINE BIOSCIENCES INC 2.8%
VERTEX PHARMACEUTICALS INC 2.6%
EXACT SCIENCES CORP 2.5%
ALNYLAM PHARMACEUTICALS INC 2.5%
ABBVIE INC 2.4%
AMGEN INC 2.2%
XBI Underweight Relative to LFSC
RADNET INC -8.8%
INTRA-CELLULAR THERAPIES INC -6.0%
WAVE LIFE SCIENCES LTD. -6.0%
LIVANOVA PLC -5.9%
MERIT MEDICAL SYSTEMS INC -5.3%
NEOGENOMICS INC -4.9%
SOLENO THERAPEUTICS INC -4.4%
COLLEGIUM PHARMACEUTICAL, INC. -4.3%
BLUEPRINT MEDICINES CORP. -4.0%
TRAVERE THERAPEUTICS, INC. -3.5%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY